Numerous health economic studies have shown that early diagnosis of Alzheimer's disease
(AD) leads to significant economic and social benefits. It has been also suggested
that an earlier intervention results in a higher probability of success when testing
new drugs. Despite this evidence, the diagnosis of AD is still made at late stages
in Europe, and even a proportion of cases remain undiagnosed. In this context, raising
awareness of the importance of early diagnosis among the general population and health
care professionals is of great importance. The development of new and more efficient
patient engagement (PE) strategies should be a priority as well.
To read this article in full you will need to make a payment
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Alzheimer's & Dementia: The Journal of the Alzheimer's AssociationAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article Info
Publication History
P3-304
Identification
Copyright
© 2018 Published by Elsevier Inc.
